EUVIMEDEUVIMED entdecken
Crossref

Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices

Paul G. Bulger, Michael T. Jones, J. Gair Ford, Kate Schrier, Kevin P. Cole, Frank Bernardoni, Olivier Dirat, Qunying Zhang, Osama Chahrour, Joy Miller, Llorente Bonaga, Andrew T. Parsons und 1 weitere

Organic Process Research & Development · 16.08.2024 · 28 (8) · 3078-3084

DOI: 10.1021/acs.oprd.4c00254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 30.07.2024. Verfasst von Paul G. Bulger und 12 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bulger, P. G., Jones, M. T., Ford, J. G., Schrier, K., Cole, K. P., Bernardoni, F., Dirat, O., Zhang, Q., Chahrour, O., Miller, J., Bonaga, L., Parsons, A. T., & Yang, L. (2024). Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices. Organic Process Research & Development, 28(8), 3078-3084. https://doi.org/10.1021/acs.oprd.4c00254

Vancouver

Bulger PG, Jones MT, Ford JG, Schrier K, Cole KP, Bernardoni F, et al. Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices. Organic Process Research & Development. 2024;28(8):3078-3084. doi:10.1021/acs.oprd.4c00254

BibTeX
@article{Bulger2024,
  author = {Bulger, Paul G. and Jones, Michael T. and Ford, J. Gair and Schrier, Kate and Cole, Kevin P. and Bernardoni, Frank and Dirat, Olivier and Zhang, Qunying and Chahrour, Osama and Miller, Joy and Bonaga, Llorente and Parsons, Andrew T. and Yang, Lan},
  title = {Risk Assessment and Control of N -Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices},
  journal = {Organic Process Research & Development},
  year = {2024},
  volume = {28},
  number = {8},
  pages = {3078--3084},
  doi = {10.1021/acs.oprd.4c00254}
}
Kostenlos starten →